This website uses cookies to enhance your browsing experience, improve site performance, and gather analytics. By selecting 'Accept,' you consent to these cookies as described in our Privacy Policy.

Towards a Wearable Alcohol Biosensor: Examining the Accuracy of BAC Estimates From New-Generation Transdermal Technology Using Large-Scale Human Testing and Machine Learning Algorithms

Sponsored by University of Illinois at Urbana-Champaign

About this trial

Last updated 7 months ago

Study ID

AA028488-01A1

Status

Recruiting

Type

Observational

Placebo

No

Accepting

18-75 Years
21+ Years
All
All

Trial Timing

Started 3 years ago

What is this trial about?

The study will employ a combined laboratory-ambulatory design. Participants will engage in ambulatory assessment over the course of 14 days, wearing biosensors assessing transdermal alcohol concentration (TAC) and providing breathalyzer readings in real-world contexts. Also during this period, participants will attend three laboratory alcohol-administration sessions scheduled at one-week intervals, with alcohol dose and rate of consumption manipulated within and between participants, respectively. Laboratory visits will also double as ambulatory orientation, check-in, and close-out sessions.

What are the participation requirements?

Yes

Inclusion Criteria

- 21 years or older

- drink alcohol at least 2x weekly

No

Exclusion Criteria

- psychological or medical conditions that might contraindicate alcohol-administration

- history of adverse reaction to type and amount of beverage used in the study

- currently seeking treatment for alcohol use disorder

- does not drink alcohol regularly

- taking drugs or medications for which alcohol consumption would be contraindicated

- women who are pregnant or are attempting to become pregnant

Locations

Location

Status

Recruiting